Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

The new arrangements were all announced in December and include a development and commercialization agreement signed with BRIG BIO, a commercial partnership with Opes Diagnostics and an expansion of ...

Researchers have used CRISPR to switch back on a gene that vanished from the human lineage roughly 20 million years ago, reviving a natural defense against excess uric acid that our ancestors once ...

Scientists have developed an experimental way to study how human embryos implant in a uterus, which may provide new insights into why miscarriages occur and how they can be prevented.

An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are ...

Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...

Biotechnology is changing fast, and it feels like every week there’s something new popping up. It’s not just about new ...